AIRLINK 209.55 Decreased By ▼ -1.42 (-0.67%)
BOP 10.46 Decreased By ▼ -0.21 (-1.97%)
CNERGY 7.35 Decreased By ▼ -0.06 (-0.81%)
FCCL 34.39 Increased By ▲ 0.82 (2.44%)
FFL 18.05 Decreased By ▼ -0.36 (-1.96%)
FLYNG 22.92 Decreased By ▼ -0.70 (-2.96%)
HUBC 132.49 Increased By ▲ 1.10 (0.84%)
HUMNL 14.14 Increased By ▲ 0.04 (0.28%)
KEL 5.03 Increased By ▲ 0.05 (1%)
KOSM 7.07 Decreased By ▼ -0.09 (-1.26%)
MLCF 45.20 Increased By ▲ 1.44 (3.29%)
OGDC 218.38 Increased By ▲ 4.82 (2.26%)
PACE 7.58 Increased By ▲ 0.13 (1.74%)
PAEL 41.70 Increased By ▲ 0.17 (0.41%)
PIAHCLA 17.30 Decreased By ▼ -0.17 (-0.97%)
PIBTL 8.55 Decreased By ▼ -0.05 (-0.58%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 189.03 Decreased By ▼ -0.57 (-0.3%)
PRL 42.33 Decreased By ▼ -1.98 (-4.47%)
PTC 25.17 Increased By ▲ 0.20 (0.8%)
SEARL 103.96 Increased By ▲ 0.59 (0.57%)
SILK 1.03 No Change ▼ 0.00 (0%)
SSGC 39.24 Decreased By ▼ -1.26 (-3.11%)
SYM 19.16 Decreased By ▼ -0.36 (-1.84%)
TELE 9.24 Decreased By ▼ -0.20 (-2.12%)
TPLP 13.10 Decreased By ▼ -0.40 (-2.96%)
TRG 69.18 Increased By ▲ 4.71 (7.31%)
WAVESAPP 10.72 Decreased By ▼ -0.18 (-1.65%)
WTL 1.71 Increased By ▲ 0.06 (3.64%)
YOUW 4.14 Decreased By ▼ -0.07 (-1.66%)
BR100 12,079 Decreased By -111.6 (-0.92%)
BR30 36,602 Increased By 19.8 (0.05%)
KSE100 116,053 Decreased By -202.4 (-0.17%)
KSE30 36,578 Decreased By -25.8 (-0.07%)

Scientists have found a genetic mutation they say protects against Alzheimer's disease and holds promise for a possible treatment for this form of dementia. More than five percent of people over the age of 60 in the Western world are believed to suffer from dementia, about two-thirds of which is due to Alzheimer's disease.
Scientists in the United States and Europe reported in the journal Nature that they had found a gene coding mutation, A673T, that protects against both Alzheimer's and cognitive decline in elderly people who do not have the disease.
"This is a mutation in a gene that makes a protein that people have believed for a long time is involved in Alzheimers," geneticist Kari Stefansson of the Icelandic medical company deCODE genetics and lead author of the paper, told AFP.
"What this mutation does is to make the protein less harmful." If you had the rare mutation, you were between five and seven times less likely to develop the disease than the general population, said Stefansson - "a very strong protection".
Probing the genetic data of some 1,800 Icelanders, the scientists also found that people between the ages of 80 and 100 who did not have Alzheimer's disease but carried the mutation had much better cognitive function than those without it.
He added there had been a lot of research in the past two decades into manipulating the amyloid precursor protein, APP, to treat Alzheimer's - an incurable and progressive disease characterised by memory loss and dementia.
The disease involves an accumulation of amyloid plaques in the brain. "This mutation could possibly represent a target for treatments to prevent Alzheimer's disease," a Nature press summary added.

Copyright Agence France-Presse, 2012

Comments

Comments are closed.